These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15814804)

  • 1. Is recombinant FVIIa the magic bullet in the treatment of major bleeding?
    Spahn DR; Tucci MA; Makris M
    Br J Anaesth; 2005 May; 94(5):553-5. PubMed ID: 15814804
    [No Abstract]   [Full Text] [Related]  

  • 2. [Using Novo Seven B in obstetric and gynecological practice--two case reports].
    Dinov P
    Akush Ginekol (Sofiia); 2005; 44 Suppl 1():9-10. PubMed ID: 16032903
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant factor VIIa for life-threatening post-partum haemorrhage.
    Ahonen J; Jokela R
    Br J Anaesth; 2005 May; 94(5):592-5. PubMed ID: 15708871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage.
    Hamaekers AE; van Mook WN; Offermans JP; Marcus MA
    Am J Crit Care; 2006 Jul; 15(4):399-401. PubMed ID: 16823017
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention and treatment of major blood loss.
    Detry O; De Roover A; Honoré P
    N Engl J Med; 2007 Sep; 357(12):1261; author reply 1261. PubMed ID: 17891839
    [No Abstract]   [Full Text] [Related]  

  • 6. Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period.
    Tanchev S; Platikanov V; Karadimov D
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):402-3. PubMed ID: 15762974
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of recombinant factor VIIa in a patient with essential thrombocythaemia with uncontrolled surgical bleeding.
    Cervera JS; Mena-Durán AV; Piqueras CS
    Thromb Haemost; 2005 Feb; 93(2):383-4. PubMed ID: 15711760
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant factor VIIa in massive postpartum haemorrhage.
    Karalapillai D; Popham P
    Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy.
    Lim Y; Loo CC; Chia V; Fun W
    Int J Gynaecol Obstet; 2004 Nov; 87(2):178-9. PubMed ID: 15491576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
    Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F
    Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant FVIIa in the treatment of warfarin bleeding.
    Berntorp E
    Semin Thromb Hemost; 2000; 26(4):433-5. PubMed ID: 11092220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.
    Levi M; Peters M; Büller HR
    Crit Care Med; 2005 Apr; 33(4):883-90. PubMed ID: 15818119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NovoSeven for non-hemophilia hemostasis.
    Med Lett Drugs Ther; 2004 Apr; 46(1181):33-4. PubMed ID: 15114252
    [No Abstract]   [Full Text] [Related]  

  • 14. [Case of massive postoperative hemorrhage after hysterectomy and successful application of Novo-Seven].
    Velev R; Nenov V; Dacheva R; Vŭtev P
    Akush Ginekol (Sofiia); 2006; 45 Suppl 2():19-22. PubMed ID: 16922341
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant activated factor VII: a new weapon in the fight against hemorrhage.
    Branch DW; Rodgers GM
    Obstet Gynecol; 2003 Jun; 101(6):1155-6. PubMed ID: 12798515
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of recombinant factor VIIa for the control of massive bleeding caused by uterine hypotonia in post-placental period].
    Tanchev S; Platikanov V; Markova S; Slavov N; Bogdanova A; Dimitrova D
    Akush Ginekol (Sofiia); 2004; 43(1):16-20. PubMed ID: 15168648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
    Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII.
    Heilmann L; Wild C; Hojnacki B; Pollow K
    Clin Appl Thromb Hemost; 2006 Apr; 12(2):227-9. PubMed ID: 16708127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Massive transfusion coagulopathy.
    Levy JH
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S59-63. PubMed ID: 16427387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of acquired von Willebrand syndrome successfully treated with recombinant Factor VIIa during thyroidectomy.
    Smaradottir A; Bona R
    Thromb Haemost; 2004 Sep; 92(3):666-7. PubMed ID: 15457604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.